| 000 | 01777 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517093426.0 | ||
| 264 | 0 | _c20180122 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep24392 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAgrawal, S | |
| 245 | 0 | 0 |
_aPioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome. _h[electronic resource] |
| 260 |
_bScientific reports _c05 2016 |
||
| 300 |
_a24392 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAlbuminuria _xetiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCreatinine _xurine |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
| 650 | 0 | 4 |
_aKidney Glomerulus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 |
_aMicrofilament Proteins _xgenetics |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aPPAR gamma _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 | _aPioglitazone |
| 650 | 0 | 4 |
_aProteinuria _xetiology |
| 650 | 0 | 4 |
_aPuromycin Aminonucleoside _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
| 650 | 0 | 4 | _aUrinalysis |
| 700 | 1 | _aChanley, M A | |
| 700 | 1 | _aWestbrook, D | |
| 700 | 1 | _aNie, X | |
| 700 | 1 | _aKitao, T | |
| 700 | 1 | _aGuess, A J | |
| 700 | 1 | _aBenndorf, R | |
| 700 | 1 | _aHidalgo, G | |
| 700 | 1 | _aSmoyer, W E | |
| 773 | 0 |
_tScientific reports _gvol. 6 _gp. 24392 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep24392 _zAvailable from publisher's website |
| 999 |
_c25985076 _d25985076 |
||